Pharma Mar SA
Pharma Mar SA (PHM) is a biopharmaceutical company based in Spain, specializing in the research, development, and commercialization of innovative marine-derived drugs for oncology. The company is a leader in marine biotechnology, leveraging its expertise in marine biology to discover novel compounds with potential therapeutic applications. Pharma Mar's core products include Yondelis, a treatment for soft tissue sarcoma and ovarian cancer, and Aplidin, used for multiple myeloma. The company operates within the pharmaceutical sector, focusing on bringing groundbreaking cancer treatments to market.